Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : : workshop summary / / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resist...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Washington, District of Columbia : : National Academies Press,, [2013] 2013 |
Year of Publication: | 2013 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (170 pages) :; illustrations (some color) |
Notes: |
|
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!